XML 25 R5.htm IDEA: XBRL DOCUMENT v3.19.1
STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating activities    
Net loss $ (216,382) $ (1,230,094)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 47,947 34,373
Gain on sale of fixed assets (1,244) 2,248
Provision for slow moving inventory 13,611 139,033
Compensation expense on stock-based arrangements with employees and consultants 52,590 41,752
Impairment of capitalized patent costs 105,665
Changes in operating assets and liabilities:    
Accounts receivable (23,098) (10,725)
Inventories (447,555) 142,312
Prepaid expenses and other current assets 3,065 (13,908)
Other assets 850
Sales incentives (99,128) 99,128
Accounts payable 230,094 39,108
Deferred compensation (61,750) 23,177
Accrued liabilities 208,113 30,559
Net cash used in operating activities (187,222) (703,037)
Investing activities    
Capitalized patent costs (81,268) (76,731)
Proceeds from sale of equipment 5,000 3,000
Purchases of equipment (26,009) (27,845)
Net cash used in investing activities (102,277) (101,576)
Financing activities    
Proceeds from issuance of notes payable to stockholders 601,273 875,000
Repayment of note payable to stockholder (250,000) (50,000)
Proceeds from stockholder loan 25,000
Payment of capital lease obligations (3,443) (3,755)
Net cash provided by financing activities 347,830 846,245
Net increase in cash 58,331 41,632
Cash at beginning of period 54,438 12,806
Cash at end of period 112,769 54,438
Supplemental cash flow information:    
Cash paid for interest 109,167 238,595
Cash paid for taxes
Noncash investing and financing activities:    
Forgiveness of stockholder loan and accrued interest 26,250 56,644
Addition to leasehold improvement as lease incentive $ 35,690